 | |
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C24H32N2O3 |
| Molar mass | 396.531 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Enadoline is a drug which acts as a highly selectiveκ-opioidagonist.
In human studies, it produced visual distortions and feelings ofdissociation, reminiscent of the effects ofsalvinorin A.[1]
It was studied as a potentialanalgesic, but abandoned because of the dose-limiting effects ofdysphoria, which could be expected from a κ-opioid agonist. There was mention of its potential in treatingcomatose head injury orstroke victims, where that type of side effect would be immaterial.[2]
When enadoline was first reported in 1990, it was "the most potent κ-selective analgesic ever reported ... 25 times more potent than morphine and 17 times more potent thanU-62066".[3]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |
